Drug Repurposing Against SARS-CoV-2
| AUTHOR | Qidwai, Tabish |
| PUBLISHER | Bentham Science Publishers (04/14/2023) |
| PRODUCT TYPE | Paperback (Paperback) |
Description
Drug repurposing is a cost-effective method of discovering new treatments for diseases than traditional drug development methods. It involves virtual screening of chemical candidates with the aid of computational methods like molecular docking. Drug Repurposing against SARS-CoV2 focuses on current trends in drug repurposing against the novel coronavirus strains. The book aims to give readers an overview of drug repurposing against COVID-19 and various techniques involved in the process. The book consolidates available information on the pathophysiology, drug targets, and drug repurposing against COVID-19 into a single, convenient resource. Key features - An up-to-date compilation of the evidence that supports the drug repurposing for COVID-19. - How to use repurposing of available drugs for disease therapy. - Provides an improved understanding of pathophysiology and SARS-CoV2 viral entry pathways. - Provides references for further reading
Show More
Product Format
Product Details
ISBN-13:
9789815123210
ISBN-10:
9815123211
Binding:
Paperback or Softback (Trade Paperback (Us))
Content Language:
English
More Product Details
Page Count:
206
Carton Quantity:
15
Product Dimensions:
7.00 x 0.54 x 10.00 inches
Weight:
1.11 pound(s)
Country of Origin:
US
Subject Information
BISAC Categories
Medical | Infectious Diseases
Descriptions, Reviews, Etc.
publisher marketing
Drug repurposing is a cost-effective method of discovering new treatments for diseases than traditional drug development methods. It involves virtual screening of chemical candidates with the aid of computational methods like molecular docking. Drug Repurposing against SARS-CoV2 focuses on current trends in drug repurposing against the novel coronavirus strains. The book aims to give readers an overview of drug repurposing against COVID-19 and various techniques involved in the process. The book consolidates available information on the pathophysiology, drug targets, and drug repurposing against COVID-19 into a single, convenient resource. Key features - An up-to-date compilation of the evidence that supports the drug repurposing for COVID-19. - How to use repurposing of available drugs for disease therapy. - Provides an improved understanding of pathophysiology and SARS-CoV2 viral entry pathways. - Provides references for further reading
Show More
List Price $71.00
Your Price
$70.29